Notice: Prescription Drug List (PDL): Multiple Additions (2021-10-21) (French, HTML)

View metadata and access the original French HTML file: Notice: Prescription Drug List (PDL): Multiple Additions (2021-10-21).

Format

HTML

Access

file-only

Publisher-reported update

2023-09-30

The purpose of this Notice of Amendment is to notify of the addition of the following medicinal ingredients on the Prescription Drug List (PDL) for human and veterinary use: Infigratinib or its salts, Lurbinectedin or its salts or derivatives, Pemigatinib or its salts, Propylthiouracil or its salts, Sacituzumab govitecan, and Sotorasib.

Access original file